Study S001577

Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07443956
Acronym: COMBAT-PsA
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: RECRUITING
Enrollment: 45
Start: 2026-03-09
Primary completion: 2028-02
Lead sponsor: NHS Greater Glasgow and Clyde
Conditions: Psoriatic Arthritis (PsA); Obesity & Overweight
Interventions: DRUG:Ixekizumab; DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Correlation of molecular changes in biopsies (skin, synovial and adipose) with weight loss [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.